HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luisa Borraccino Selected Research

vabicaserin

10/2021New Pharmacological Targets for the Treatment of Schizophrenia: A Literature Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luisa Borraccino Research Topics

Disease

1Cognitive Dysfunction
10/2021
1Neurobehavioral Manifestations
10/2021
1Psychotic Disorders (Schizoaffective Disorder)
10/2021
1Schizophrenia (Dementia Praecox)
10/2021
1Alzheimer Disease (Alzheimer's Disease)
01/2021
1Amyloid Plaque
01/2021

Drug/Important Bio-Agent (IBA)

1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2021
1N-Methylaspartate (NMDA)IBA
10/2021
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
10/2021
1vabicaserinIBA
10/2021
1Cycloserine (Seromycin)FDA Link
10/2021
1ErythropoietinFDA Link
10/2021
1Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2021
1Memantine (Namenda)FDA Link
10/2021
1Oxytocin (Pitocin)FDA LinkGeneric
10/2021
1Antipsychotic Agents (Antipsychotics)IBA
10/2021
1CalciumIBA
01/2021
1Vitamin DFDA LinkGeneric
01/2021

Therapy/Procedure

1Therapeutics
01/2021